Keyphrases
Prostate Cancer Cell Lines
100%
Comprehensive Evaluation
100%
Aggression
100%
Enhancer of Zeste Homolog 2 (EZH2)
100%
Overexpression
40%
Androgen-independent
40%
Prostate Cancer
30%
Prostate Tumor
20%
Treatment Options
10%
Initial Treatment
10%
Advanced Stage
10%
Neoplastic Transformation
10%
Prostate Cells
10%
Prostate Cell Line
10%
Improved Outcomes
10%
Knockdown
10%
Recurring
10%
Neoplastic Growth
10%
Tumor
10%
Aggressive Tumor
10%
Strong Correlation
10%
Tumorigenicity
10%
Phenotypic Effects
10%
Multiple Cell Lines
10%
Metastasizing
10%
Neoplasm Invasion
10%
LNCaP
10%
DU145
10%
Aggressive Behavior
10%
Aggressive Prostate Cancer
10%
Polycomb Group (PcG) Proteins
10%
Enhancer of Zeste
10%
22Rv1
10%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
100%
EZH2
100%
Downregulation
10%
Polycomb-Group Proteins
10%
LNCaP
10%
Enhancer Protein
10%